Hexoskin raises almost $1M for its smart apparel
The company plans to use the funds to apply for an FDA clearance for a new line of smart clothing products that will be used for medical monitoring.
Chiron Health raises $2.3M seed round, launches an iPhone and iPad app
The company is focused on the technology needs of physician practices to enable telemedicine encounters with their existing patient base.
Vidyo gets $15M in a round led by Kaiser Permanente Ventures
The company's VidyoWorks platform integrates HD video communications into EHR systems and workflow redefining a new era in telemedicine and healthcare.
EU’s online doctor booking startup Doctena raises €4.5M to expand beyond Benelux
The investment came from private investors, business angels, and debt; and the funds will be used to expand to other countries, starting with Switzerland.
Mazlo raises $10M for its personal development programs
Seattle-based company offers programs that combine the expert guidance and human connection of in-person coaching with the convenience of digital content.
Savonix raises $1.5M seed for its mental health platform
The company says it offers the only mobile evidence-based digital neuro-cognitive assessment and health platform to deliver clinical grade results and insights.
Vitals raises $41M from Goldman Sachs and existing investors
The funds will support the continued expansion of the company's health care price transparency and consumer engagement solutions.
One Medical raises $65M to expand to other markets
The company already offers same-day appointment booking, prescription renewals, messaging and digital dermatology, and plans to further expand its offering.
MD Revolution raises $23M for its chronic care management platform
The company has developed an end-to-end chronic care management (CCM) and patient engagement solutions, which now serve more than 100 practices.
Twine Health raises $6.75M Series A for its health coaching platform
The company already demonstrated effectiveness in hypertension and diabetes care, and is expected to be equally successful in other chronic conditions.